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T cell progenitors derive from the bone marrowbutmust migratevia bloodstream to the thymus in order
to differentiate. The mechanism by which the thymus recruits progenitors from the blood is unknown.
It is known, however, that there are receptive and refractory periods for progenitor recruitment and that
whencells are imported,theyenter the thymus throughpost-capillary venules. Therefore, recruitment is
an active process temporally and spatially regulated. In order to characterize the mechanism of
recruitment, we evaluated vascular signals known to regulate leukocyte extravasation, with respect to
their intrathymic location and temporal ﬂuctuations. We ﬁnd that CD34, MECA79, VCAM-1, ICAM-1
and VAP-1 are all expressed in thymic blood vessels. MECA79 and VAP-1 appear to be speciﬁc for
post-capillary venules, while ICAM-1 and VCAM-1 are also found on intrathymic stromal cells.
MAdCAM is also expressed in the thymus, but is not associated with vascular tissues. Only MECA79 is
upregulated during recruitment peaks, suggesting a role for this molecule in the periodicity of
recruitment. Together, these studies reveal potential roles for L-selectin ligands, VCAM-1, ICAM-1 and
VAP-1 in progenitor recruitment to the thymus, and implicate the presence of other periodic signals,
such as chemokines and cytokines, that cooperate to execute this essential function.
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INTRODUCTION
T cell progenitors are generated in the bone marrow and
travel through the blood stream to enter the thymus, where
they develop into mature T cells. However, there is little
published information regarding the molecular mechan-
isms by which progenitors are recruited to the post-natal
thymus. Our laboratory and others have shown that T cell
progenitors enter the thymus through large blood vessels
near the cortico-medullary junction (Brumby and Metcalf,
1967; Brahim and Osmond, 1970; Kyewski, 1987; Dunon
et al., 1997; Lind et al., 2001). This recruitment of T cell
progenitors to the thymus is an active phenomenon (Foss
et al., 2001; 2002); the thymus is receptive to progenitor
entry for approximately 1 week, followed by a 3-week
refractory period. The availability of undeﬁned intrathy-
mic stromal niches is thought to regulate the status of cell
entry, such that once intrathymic sites are saturated with
prothymocytes, new progenitors are not able to enter until
the intrathymic progenitors move on and leave the niches
empty (Foss et al., 2001; 2002). Together, the data on the
restricted location of cell entry, and the periodicity of this
process, indicate that progenitor recruitment to the thymus
is regulated both spatially and temporally.
The process of leukocyte extravasation is fairly well
characterized in secondary lymphoid organs and sites of
chronic inﬂammation (Campbell and Butcher, 2000;
Worthylake and Burridge, 2001). The ﬁrst steps in the
process are rolling and tethering, mediated by selectins
and their ligands. L-Selectin ligands, which include CD34
(Baumheter et al., 1993), GlyCAM (Mebius et al., 1993)
and MadCAM (Berg et al., 1993) can be modiﬁed post-
translationally with carbohydrates such as MECA79
(Hemmerich et al., 1994), which are necessary for optimal
ligand binding. Subsequently, integrins are required to
mediate ﬁrm adhesion, and expression of their ligands,
including the canonical ligands MAdCAM-1 (de Chateau
et al., 2001; Salas et al., 2002), ICAM-1 (Springer, 1994;
Salas et al., 2002) and VCAM-1 (Weber and Springer,
1998), are required for this process. Some of these,
including ICAM-1 and VCAM-1 are upregulated in
response to pro-inﬂammatory cytokines and chemokines
(Osborn et al., 1989; Xu et al., 1994). In addition,
Vascular Adhesion Protein-1 (VAP-1) is a member of a
newly described class of adhesion molecules that differ in
the expression of both an adhesion domain and a catalytic
domain. VAP-1 has a known role in leukocyte extravasa-
tion (for a review see, Salmi and Jalkanen, 2001),
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and TNFa (Arvilommi et al., 1997).
In the present manuscript, we characterize expression of
some of the canonical mediators of leukocyte extravasa-
tion (described above) in thymic progenitor seeding.
We show that post-capillary venules in the post-natal
thymus express a number of adhesion molecules related to
rolling, tethering and ﬁrm adhesion, suggesting a potential
role for these in the extravasation process. Ofinterest, only
one of these, MECA79, is regulated with respect to the
periodicity of progenitor recruitment, implicating the
regulation of other signaling molecules, possibly includ-
ing chemokines and/or inﬂammatory cytokines, in
regulating the periodicity of this process.
MATERIALS AND METHODS
Mice and Antibodies
C57BL/6 male mice were purchased from NCI and kept
under SPF conditions at MemorialSloan-Kettering Cancer
Center. Rat anti-mouse MAdCAM-1 was a gift from
Dr Klaus Ley, University of Virgina; Rat anti-mouse
CD34 was a kind from Dr Steven Nimer, MSKCC; Rat
anti-mouse PNAd (MECA79) was purchased from BD
Pharmingen; Hamster anti-mouse ICAM-1 (Pharmingen)
was a gift from Dr Ralph Steiman, Rockefeller University;
Rat anti-mouse VCAM-1 (clone M/K-2.7) was generated
in the investigator’s laboratory; Rat anti-mouse VAP-1
(Monoclonal antibody 7–188 against mouse VAP-1
molecule was produced in rat, detailed description will
be published separately); biotin conjugated rabbit anti-rat
IgG was purchased from Vector Laboratories; biotin
conjugated rabbit anti-rat IgG þ IgM and biotin con-
jugated goat anti-Armenian hamster IgG were purchased
from Jackson ImmunoResearch.
Tissue Sectioning and Freezing
Thymuses were harvested from mice and lobes separated
with thin forceps. Corresponding lobes from mice of 4, 5,
7 and 9 weeks of agewere immediately frozen side by side
in the same mold in OCT Tissue Tech reagent (VWR).
Transverse frozen sections of 5mm thickness were taken
at 2, 3, 4, 5 and 6mm depths relative to the anterior–
posterior axis (the thymus is generally 7mm from anterior
to posterior). Sections were stored at 2208Ci na
desiccated box until use.
Immunohistochemistry
Dessicated frozen sections were ﬁxed in ice-cold acetone
for 30min. Endogenous peroxidase activity was quenched
by incubating slides for 30min in a solution of 1mM
NaN3, 10mM glucose, and 1U/ml of glucose oxidase
(Calbiochem). Incubation in Avidin/biotin Blocking Kit
(Vector laboratories) for endogenous biotin quenching,
followed by 5% Fetal Bovine Serum (FBS) incubation for
blocking non-speciﬁc binding were performed before
antibody incubations. All antibody incubations were
performed for 30min at room temperature. Single-color
histochemical detection was performed using an avidin-
peroxidase conjugate system (VectaStain Elite; Vector
Laboratories), and antibody-enzyme complex was visual-
ized with 3030-diaminobenzidene (DAB; Sigma-Aldrich)
and 0.1% H2O2. Incubation times were carefully moni-
tored to prevent saturation, thus favoring visualization of
differences in expression levels. Sections were counter-
stained using Mayer’s hematoxylin (Fisher Scientiﬁc),
dehydrated through graded ethanol, cleared in Hemo-De
(Fisher Scientiﬁc), and cover slipped using Permount
(Fisher Scientiﬁc) for examination. Photomicrographs
were taken using an Olympus BX40 microscope and
Pixera Studio version 1.2 software (Pixera Corporation).
RESULTS
MECA79 is Expressed in Post-capillary Venules in the
Adult Mouse Thymus
When expression of MECA79, one of the carbohydrate
structures that modify ligands for L-selectin, was
examined by immunohistochemistry, it was found to be
expressed mainly on post-capillary venules deep in the
cortex or in the cortico-medullary junction (Fig. 1).
Expression of MECA79 appeared to be higher in tissues
from animals at 5 and 9 weeks of age (peak of progenitor
recruitment), and weaker in tissue from animals at 4 and 7
weeks of age (refractory periods). Proteins modiﬁed by
MECA79, such as CD34 (Suzuki et al., 1996), are not
restricted to post-capillary venules at the cortico-
medullary junction, but rather are expressed by all
vascular elements in the mouse thymus. Together, these
ﬁndings indicate that the signals that regulate both the
periodicity and the location of progenitor recruitment to
the thymus may involve post-translational changes in
scaffold proteins, rather than alterations in adhesion
molecule synthesis per se.
VCAM-1 and ICAM-1 are Expressed by both Thymic
Stromal Cells and Post-capillary Venules
Figures 2 and 3 show immunohistochemical analysis of
VCAM-1 and ICAM-1, respectively. VCAM-1 was found
to be expressed in venules near the cortico-medullary
junction, as well as in the deep cortex and medulla, and
was also present on some stromal cells (Fig. 2). However,
the levels of VCAM-1 on vascular cells appeared to be
signiﬁcantly higher than those found on stromal cells.
No differences in VCAM-1 expression were found in
thymic sections from animals at different ages (4–9
weeks), indicating that while VCAM-1 may play a role in
facilitating progenitor homing to the thymus, it does not
appear to be involved in the periodicity of this event.
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expressed by blood vessels deep in the tissue, both in the
cortex and in the medulla (Fig. 3). Again, there appears to
be differential expression of ICAM-1 among the blood
vessels present. Some of the larger ones displayed a
stronger, sharper staining in the luminal aspect of the
vessel (Fig. 3B, arrow), while other smaller vessels
presented a more homogenous and weaker staining. Some
stromal cells also expressed ICAM-1, both in the cortex
and in the medulla. It is difﬁcult to say whether the
apparently higher expression by stromal cells in the
medulla is truly higher than it is in the cortex (see Fig. 3B,
for details), or whether the apparent difference is a
consequence of the differences in cell density in each
compartment. In any case, ICAM-1 is present, and its
expression does not appear to vary in relation to animal
age, suggesting that like VCAM-1, it may play a role in
progenitor entry into the thymus, although not in the
periodicity of this process.
VAP-1 Expression is Restricted to Speciﬁc Venules
found near the Sites of Progenitor Homing
Analysis of VAP-1 expression showed that it was
restricted to blood vessels, and more precisely, to a
relatively few venules found near the corticomedullary
junction (Fig. 4). VAP-1 expression was not homogenous
in most cases, showing a general bias towards the cortical
aspects of the vessels where it was expressed. Venules
within the medullary compartment did not express VAP-1,
FIGURE 2 VCAM expression on thymic stromal cells and endothelial cells of postcapillary venules. VCAM expression was examined by
immunohistochemistry on thymuses from animals at 4 weeks (A and D), 5 weeks (B and E), 7 weeks (C and F) and 9 weeks (D and H) of age. Regions
deﬁned on the low power images (A–D, 100 £ original magniﬁcation) are enlarged in panels E–F (400 £ original magniﬁcation). Positive staining
was observed at a relatively higher level on blood vessels (arrows) than on stromal cells (arrowheads). Inset in panel D shows an isotype-matched
antibody control. M ¼ medulla; C ¼ cortex.
FIGURE 1 MECA79 is expressed on speciﬁc vascular structures in the mouse thymus. MECA79 was examined by immunohistochemistry on thymic
sections of animals at 4 weeks (A), 5 weeks (B), 7 weeks (C and E) and 9 weeks (D and F) of age; these intervals encompass one complete cycle of
progenitor recruitment (see text for further details). MECA79 expression was found on most venules near the sites of progenitor entry, and was most
abundant at peak periods of progenitor recruitment (i.e. 5 and 9 weeks), and lower during refractory periods (4 and 7 weeks). Regions outlined by
rectangles in panels C and D are enlarged in panels E and F, respectively. The inset on panel E shows thymic expression of CD34, one of the sialomucins
that can be modiﬁed by MECA79; the inset on panel F is an isotype-matched antibody control. Original magniﬁcations: A through D, 100 £ ; E and F,
400 £ .M¼ medulla; C ¼ cortex.
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expression did not appear to change during peak or
refractory periods of progenitor homing to the thymus.
These results strongly implicate VAP-1 in the process of
recruiting progenitors to the thymus, but again, VAP-1
does not appear to be related to the periodicity of entry.
MAdCAM-1 is Expressed in the Thymus, but not by
Endothelial Cells
MAdCAM-1 is an adhesion molecule most frequently
involved in rolling and tethering of leukocytes in the
circulation. In the thymus, MAdCAM-1 is expressed, but
it appears to be restricted to a relatively few cells found
within the medulla proper (Fig. 5). Based on their
morphology, these appear to be stromal cells, although
they are clearly not present in sufﬁcient number to include
all medullary stroma. Blood vessels in the thymus are
categorically negative for MAdCAM-1, even though the
same concentrations of antibody readily detected MAd-
CAM-1 in sections of mesenteric lymph node. Thus,
although MAdCAM-1 is expressed in the thymus, it does
not appear to be associated with blood vessels and is
therefore unlikely to be involved in any aspect of
progenitor recruitment.
DISCUSSION
In the present manuscript, we show that blood vessels in
the post-natal thymus express a variety of adhesion
molecules that facilitate leukocyte extravasation in
secondary lymphoid organs or in inﬂamed tissue. Only
one of these, MECA79, ﬂuctuated temporally with
respect to periods of progenitor recruitment, being
highest during homing peak periods. MECA79 has
previously been shown to be present in the medulla of the
AKR hyperplastic thymus (Michie et al., 1995). Here,
we ﬁnd it to be expressed by postcapillary venules at the
sites where progenitors are known to enter the post-natal
thymus. Since CD34, which is one of the sialomucins that
can be modiﬁed by MECA79, is expressed on all thymic
vasculature, this ﬁnding suggests that post-translational
modiﬁcation, rather than protein synthesis, may be a
critical factor regulating the periodicity of progenitor
FIGURE 3 ICAM-1 is expressed by endothelial and stromal cells in the
mouse thymus. Panel A shows a low magniﬁcation (100 £ ) image of
ICAM-1 immunohistochemical staining; inset shows an isotype-matched
antibody control. Staining was strongest in the medulla and lower in
the cortex, but was basically expressed throughout the thymus.
No differences were found with respect to thymic homing potential
(see text). The area indicated by a rectangle is enlarged in a high power
(400 £ original magniﬁcation) image in B. A few post-capillary vessels
are indicated by arrows; some of these show a distinction in the intensity
of staining between luminal and abluminal aspects (see text).
M ¼ medulla, C ¼ cortex.
FIGURE 4 VAP-1 expression is restricted to a subset of venules found
near the sites of progenitor homing. Panel A shows a low power image
(40 £ original magniﬁcation) with an anti-VAP-1 antibody. Inset is an
isotype-matched antibody control; rectangles show regions of interest
enlarged in Panels B and C (400 £ original magniﬁcation). Parts of some
venules near the cortico-medullary junction express high levels of VAP-1
(arrows), while others are very weakly stained or completely absent
(arrowheads). M ¼ medulla, C ¼ cortex.
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feedback induced by niche occupancy in the thymus
(Foss et al., 2001; 2002) may activate stromal and/or
endothelial cells to upregulate enzymes such as 6-O
GlcNAc sulfotransferase, which are required for such
post-translational modiﬁcations (Hemmerich et al.,
2001). In any case, our results suggests that L-selectin
ligands may play a role in progenitor recruitment to the
thymus, and that post-translational modiﬁcation of
L-selecting ligands may be involved in regulating the
periodicity of this event. MAdCAM-1, another sialo-
mucin that can be modiﬁed by MECA79, was not found
in association with blood vessels in the adult thymus, but
others have reported it to be expressed by thymic venules
at around the time of birth (Iizuka et al., 2000),
suggesting that it might play a role in progenitor
recruitment during embryonic development or in the ﬁrst
perinatal wave of T cell production (Dunon et al., 1993).
Although they did not ﬂuctuate with respect to periods
of homing activity, other adhesion markers were found to
be expressed by thymic vascular cells as well. Both
ICAM-1 and VCAM-1 were found in thymic blood
vessels, including post-capillary venules at the cortico-
medullary junction, indicating a potential role for these
molecules in leukocyte extravasation into the thymus.
We also found both of these to be expressed by thymic
stromal cells. We and others have previously found
VCAM-1 expression by thymic stroma (Salomon et al.,
1997; Prockop et al., 2002), and we have shown it to be a
critical ligand for transcortical migration of intrathymic
progenitors (Prockop et al., 2002). Likewise, ICAM-1 has
been shown by others to be expressed on various
thymocytes, including thymocytes themselves (Reiss and
Engelhardt, 1999), nurse cells (Cordes et al., 1997;
Oliveira-dos-Santos et al., 1997), and other stromal cells
(Reiss and Engelhardt, 1999; Lucas and Germain, 2000).
While we did not observe any differences in ICAM-1
expression on vascular cells with respect to the periodicity
of progenitor homing, we did observe a difference in the
pattern of staining on different types of vessels (see
“Results” section), although the implications of this are
presently unknown.
Although they did not ﬂuctuate with respect to homing
activity, the expression patterns shown by VAP-1 in the
thymus are particularly interesting for other resons. VAP-1
was restricted to only a very few venules, and all of these
were near the sites of progenitor entry at the cortico-
medullary boundary. Furthermore, in venules that actually
span the border of cortical and medullary regions, the
distribution of VAP-1 was asymmetric with higher
expression towards the cortical aspect of the vessel,
whereas in deep cortical venules that do not contact the
medulla, distribution was homogenous around the
perimeter. Thus, VAP-1, which could be involved in
rolling/tethering, diapedesis, or both (Salmi and Jalkanen,
2001), displays a pattern of expression that is consistent
with directing cell entry speciﬁcally in the region of the
peri-medullary cortex, as previously shown (Lind et al.,
2001). Further, the fact that VAP-1 is only expressed on a
small subset of venules in this region is consistent with the
small numberof cells that enter the thymus at any one time
(Shortman et al., 1990). Thus, VAP-1 appears to have
signiﬁcant potential as a candidate regulating the
speciﬁcity of progenitor homing to the post-natal thymus
via the blood.
Overall, it is interesting to note that with the exception
of MECA79, none of the other adhesion molecules tested
here were modulated with respect to the status of new
progenitor recruitment by the thymus. It is possible that
ﬂuctuations in MECA79 expression are sufﬁcient to
regulate the periodicity of this process. However, in other
tissues where leukocyte recirculation does not occur
constitutively, other factors, such as inﬂammatory
cytokines, are generally required to facilitate the
extravasation process (Smith et al., 1991; Vaday et al.,
2001). Chemokines are also heavily implicated, both in
FIGURE 5 MAdCAM-1 is expressed in the thymus, but not by
endothelial cells. MAdCAM-1 expression was examined by
immunohistochemistry on thymus. Cells expressing MAdCAM-1
(arrowheads) are found within medullary (M) areas, but not in the
cortex (C). For comparison, the location of a large post-capillary venule
is indicated by an arrow. The inset shows an isotype-matched antibody
control. Panel B shows a high power image of the central region in Panel
A, illustrating the morphology of MAdCAM-1-expressing cells. The
inset on Panel B shows MAdCAM-1 staining on mesenteric lymph node.
Thymuses from animals of all ages tested showed similar results.
Original magniﬁcations: Panel A, 200 £ , Panel B, 400 £ .
VASCULAR HOMING SIGNALS IN THE THYMUS 31inﬂammed tissue and in tissues where leukocyte
recirculation is constitutive (Bargatze and Butcher,
1993; Rossi and Zlotnik, 2000; Mackay, 2001). Since
adhesion molecules expressed by thymic endothelial cells
are also found on blood vessels in a variety of other
tissues, it is likely that additional signals are required to
impart speciﬁcity to the thymic homing process. Thus,
although critical reagents are generally lacking at present,
characterization of cytokine and chemokine expression
in situ at the sites of progenitor entry is likely to yield
important information about the recruitment process.
Together with characterization of adhesion molecule
expression, such as presented here, such data will provide
important insights into the regulation of the critical and
poorly understood process of progenitor recruitment to the
thymus in the steady state.
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